Ojoylan, Baby Boy .
HRN: 25-67-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2024
AMPICILLIN 250MG (VIAL)
08/08/2024
08/15/2024
IV
135
Q12
PSNb
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes